We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PBE market cap is 263.06M. The company's latest EPS is USD 5.9498 and P/E is 11.00.
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 761k | 1.32M | 719k | 1.17M | 1.18M |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | 14.14M | 2.18M | 86.4M | -74.81M | 23.92M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End 30 April 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 255.62M | 227.25M | 330.82M | 262.34M | 289.09M |
Total Liabilities | 7.59M | 6.64M | 42.98M | 54.15M | 37.43M |
Total Equity | 248.03M | 220.61M | 287.83M | 208.19M | 251.66M |
Market Cap | 263.06M |
Price to Earnings Ratio | 11.00 |
Price to Sales Ratio | 223.88 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 1.05 |
Dividend Yield | - |
Shares Outstanding | 4.02M |
Average Volume (1 week) | 4.72k |
Average Volume (1 Month) | 18.75k |
52 Week Change | 4.38% |
52 Week High | 67.76 |
52 Week Low | 52.47 |
Spread (Intraday) | 6.05 (8.94%) |
Company Name | Invesco Biotechnology and Genome ETF |
Address |
155 federal st boston, massachusetts 02110 |
Website | https://www.invesco.com |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions